Nikolaos Spyrou

7PUBLICATIONS
36CO-AUTHORS
Respiratory diseasesInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Genomics and transcriptomicsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 14, 2023
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.

Yu Akahoshi, Nikolaos Spyrou, William J Hogan

|Sep 12, 2022
Effective treatment of low-risk acute GVHD with itacitinib monotherapy.

Aaron Etra, Alexandra Capellini, Amin Alousi

|Apr 20, 2022
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.

Aaron Etra, Stephanie Gergoudis, George Morales

|Jan 18, 2022
Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs.

Georgios Asimomitis, André G Deslauriers, Andriana G Kotini

Pageof 2